Quorum Innovations Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

Quorum Innovations General Information

Description

Developer of a biotech therapeutics company intended to discover and develop clinical therapeutics from human commensal biofilm microbiota. The company's technology focuses on human microbiome-derived biotherapeutics designed to treat barrier deficiency states, the therapeutics engage the body's immune system to treat a broad range of pathogens in biofilm form, enabling physicians to solve the problem of antibiotic resistance.

Contact Information

Formerly Known As
Quorum Biofilm Research Laboratories
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 2068 Hawthorne Street
  • Sarasota, FL 34236
  • United States
+1 (941)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2068 Hawthorne Street
  • Sarasota, FL 34236
  • United States
+1 (941)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quorum Innovations Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Early Stage VC (Series A) Cancelled Generating Revenue
2. Early Stage VC Completed Generating Revenue
1. Debt - General 06-Feb-2014 Completed Generating Revenue
To view Quorum Innovations’s complete valuation and funding history, request access »

Quorum Innovations Patents

Quorum Innovations Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022379963-A1 Materials and methods for preventing or reducing toxicity to organophosphates and other toxic materials Inactive 05-Nov-2021
CA-3239288-A1 Materials and methods for preventing or reducing toxicity to organophosphates and other toxic materials Pending 05-Nov-2021
EP-4426328-A1 Materials and methods for preventing or reducing toxicity to organophosphates and other toxic materials Inactive 05-Nov-2021
US-20250025528-A1 Materials and methods for preventing or reducing toxicity to organophosphates and other toxic materials Pending 05-Nov-2021
WO-2023081873-A1 Materials and methods for preventing or reducing toxicity to organophosphates and other toxic materials Inactive 05-Nov-2021 A61K38/164
To view Quorum Innovations’s complete patent history, request access »

Quorum Innovations Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quorum Innovations FAQs

  • When was Quorum Innovations founded?

    Quorum Innovations was founded in 2010.

  • Where is Quorum Innovations headquartered?

    Quorum Innovations is headquartered in Sarasota, FL.

  • What is the size of Quorum Innovations?

    Quorum Innovations has 6 total employees.

  • What industry is Quorum Innovations in?

    Quorum Innovations’s primary industry is Drug Discovery.

  • Is Quorum Innovations a private or public company?

    Quorum Innovations is a Private company.

  • What is Quorum Innovations’s current revenue?

    The current revenue for Quorum Innovations is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process